Evaluating the performance characteristics of different antimicrobial susceptibility testing methodologies for testing susceptibility of gram-negative bacteria to tigecycline

Molecular Characterization of Tigecycline Non-Susceptibility among Extensively Drug-Resistant Acinetobacter baumannii Isolates of Clinical Origin

(2021) Mehri Haeili et al.   CHEMOTHERAPY

The Rapid Emergence of Tigecycline Resistance in blaKPC–2 Harboring Klebsiella pneumoniae, as Mediated in Vivo by Mutation in tetA During Tigecycline Treatment

(2018) Xiaoxing Du et al.   Frontiers in Microbiology

Molecular Epidemiology and Drug Resistance Pattern of Carbapenem-Resistant Klebsiella pneumoniae Isolates from Iran

(2018) Zeinab Jafari et al.   Microbial Drug Resistance

Tigecycline treatment in an infant with extensively drug-resistant Acinetobacter baumannii bacteremia

(2017) Jiawei Zeng et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

The Ribosomal S10 Protein Is a General Target for Decreased Tigecycline Susceptibility

(2015) Kathryn Beabout et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Tigecycline activity tested against carbapenem-resistant Enterobacteriaceae from 18 European nations: results from the SENTRY surveillance program (2010–2013)

(2015) Helio S. Sader et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

In vitro activity of tigecycline and comparators against carbapenem-resistant Enterobacteriaceae in Africa–Middle East countries: TEST 2007–2012

(2014) M.I. Renteria et al.   Journal of Global Antimicrobial Resistance

The emergence of clinical resistance to tigecycline

(2012) Yan Sun et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Agreement Assessment of Tigecycline Susceptibilities Determined by the Disk Diffusion and Broth Microdilution Methods among Commonly Encountered Resistant Bacterial Isolates: Results from the TigecyclineIn VitroSurveillance in Taiwan (TIST) Study, 2008 to 2010

(2011) Jien-Wei Liu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

ramR Mutations in Clinical Isolates of Klebsiella pneumoniae with Reduced Susceptibility to Tigecycline

(2010) M. Hentschke et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Influence of different Mueller–Hinton agars and media age on Etest susceptibility testing of tigecycline

(2010) Thean Yen Tan et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Influence of Media and Testing Methodology on Susceptibility to Tigecycline of Enterobacteriaceae with Reported High Tigecycline MIC

(2010) M. Torrico et al.   JOURNAL OF CLINICAL MICROBIOLOGY

High Concentrations of Manganese in Mueller-Hinton Agar Increase MICs of Tigecycline Determined by Etest

(2009) C. Fernandez-Mazarrasa et al.   JOURNAL OF CLINICAL MICROBIOLOGY

In Vitro Activity of Tigecycline against Gram-Positive and Gram-Negative Pathogens as Evaluated by Broth Microdilution and Etest

(2008) C. M. Pillar et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances

(2008) Irith Wiegand et al.   Nature Protocols